Cost Per Responder Analysis of Guselkumab versus Adalimumab using Efficacy Results fromm a Head-to-Head Clinical Trial in Patients with Moderate to Severe Plaque Psoriasis. J of Skin. 2017;1(3.1):s6. doi:10.25251/skin.1.supp.5